Amersham Nabs Worldwide Rights to SurModics 3-D Array Slides | GenomeWeb

NEW YORK, Nov. 19 - Amersham Biosciences' purchase of Motorola's CodeLink business over the summer has also won Amersham exclusive worldwide rights to certain 3-D microarray slides made by SurModics, Amersham said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.